A comparative study of 188Re(V)-meso-DMSA and 188Re(V)-rac-DMSA: preparation and in vivo evaluation in nude mice xenografted with a neuroendocrine tumor

Nuclear Medicine and Biology

Volumn 34, Issue 8, 2007, Pages 1029-1036

  Park, Jun Young ^a,b   Lee, Tae Sup ^c   Choi, Tae Hyun ^c   Cheon, Gi Jeong ^c   Choi, Chang Woon ^c   Awh, Ok Doo ^b  

^a Yonsei University Wonju   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

188Re; Diastereomer; Dimercaptosuccinic acid (DMSA); Neuroendocrine tumor; PC 12; Radiotherapy

Indexed keywords

RADIOPHARMACEUTICAL AGENT; RHENIUM 188; SODIUM METABISULFITE; SUCCIMER RE 188; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND; RHENIUM(V)DIMERCAPTOSUCCINIC ACID; SUCCIMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SCREENING; FEMALE; ISOMER; ISOTOPE LABELING; MOUSE; NEUROENDOCRINE TUMOR; NONHUMAN; PH MEASUREMENT; RADIOCHEMISTRY; ROOM TEMPERATURE; SCINTILLATION CAMERA; SYNTHESIS; TUMOR LOCALIZATION; XENOGRAFT; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CELL LINE; METABOLIC CLEARANCE RATE; METABOLISM; NUDE MOUSE; PHEOCHROMOCYTOMA; RAT; SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; CELL LINE; FEMALE; ISOTOPE LABELING; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; MICE, NUDE; ORGAN SPECIFICITY; ORGANOMETALLIC COMPOUNDS; PHEOCHROMOCYTOMA; RADIOPHARMACEUTICALS; RATS; SUCCIMER; TISSUE DISTRIBUTION;

EID: 35848954515     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.06.016     Document Type: Article

References (34)

1. 99mTc(V) dimercaptosuccinic acid, a new tumour-seeking agent. Nucl Med Commun 9 (1988) 105-116
2. Watkinson J.C., Shaheen O.H., and Clarke S.E. An evaluation of the uptake of technetium 99m(V)-dimercaptosuccinic acid in patients with squamous carcinoma of the head and neck. Clin Otolaryngol 12 (1987) 405-411
3. Kobayashi H., Sakahara H., Hosono M., Shirato M., Endo K., Kotoura Y., et al. Soft-tissue tumours: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy. Radiology 190 (1994) 277-280
4. 99mTc(V)-DMSA in lung metastases of osteosarcoma. Ann Nucl Med 3 (1989) 37-40
5. Lam A.S.K., Kettle A.G., O'Doherty M.J., Coakley A.J.C., Barrington S.F., and Blower P.J. Pentavalent technetium-99m-DMSA imaging in patients with bone metastases. Nucl Med Commun 18 (1997) 907-914
6. Mausner L.F., and Srivastava S.C. Selection of radionuclides for radioimmunotherapy. Med Phys 20 (1993) 503-509
7. 188Re(V)-meso-2,3-dimercaptosuccinic acid. Nucl Med Biol 27 (2000) 309-314
8. 2dmsa=meso-2,3-dimercaptosuccinic acid). J Chem Soc Chem Commun (1991) 1115-1117
9. Food and Drug Administration. Fed Regist 54 (1989) 7103
10. Fang X., Hua F., and Fernando Q. Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models. Chem Res Toxicol 9 (1996) 284-290
11. Fang X., and Fernando Q. Stereoisomeric selectivity of 2,3-dimercaptosuccinic acids in chelation therapy for lead poisoning. Chem Res Toxicol 8 (1995) 525-536
12. Fang X., and Fernando Q. Synthesis, structure and properties of rac-2,3-dimercaptosuccinic acid, a potentially useful chelating agent for toxic metals. Chem Res Toxicol 7 (1994) 148-156
13. Rindi G., Villanacci V., Ubiali A., and Scarpa A. Endocrine tumors of the digestive tract and pancreas: histogenesis, diagnosis and molecular basis. Expert Rev Mol Diagn 1 (2001) 323-333
14. Kaltsas G.A., Besser G.M., and Grossman A.B. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 25 (2004) 458-511
15. Solcia E., Klöppel G., and Sobin L.H. Histological typing of endocrine tumours. World Health Organization International histological classification of endocrine tumors. 2nd ed. (2000), Springer, New York
16. Rufini V., Calcagni M.L., and Baum R.P. Imaging of neuroendocrine tumors. Semin Nucl Med 36 (2006) 228-247
17. Shapiro B., Gross M.D., and Shulkin B. Radioisotope diagnosis and therapy of malignant pheochromocytoma. Trends Endocrinol Metab 12 (2001) 469-475
18. Ohta H., Yamamoto K., Endo K., Mori T., Hamanaka D., Shimazu A., et al. A new imaging agent for medullary carcinoma of the thyroid. J Nucl Med 25 (1984) 323-325
19. 99mTc(V)-dimercaptosuccinic acid (DMSA) for imaging medullary carcinoma of the thyroid and its metastases. Eur J Nucl Med 13 (1988) 507-510
20. 99mTc]MDP - an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J Nucl Med 29 (1988) 33-38
21. Gerecke M., Friedheim E.A.H., and Brossi A. Studies of 2,3-dimercaptosuccinic acid. Helv Chim Acta 44 (1961) 955-960
22. 188Re(V)-DMSA revisited: preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake. Nucl Med Commun 19 (1998) 173-181
23. 186/188Re(V)-DMSA is significantly reduced when the reducing agent is changed from stannous ion to metabisulfite. J Label Compd Radiopharm 45 (2002) 675-686
24. 188Re]-pentavalent rhenium dimercaptosuccinic acid complex. Nucl Med Commun 14 (1993) 197-203
25. 186Re]rhenium(V)dimercaptosuccinic acid: a possible tumour radiotherapy agent. Appl Radiat Isot 42 (1991) 167-171
26. Watkinson J.C., Lazarus C.R., Mistry R., Shaheen O.H., Maisey M.N., and Clarke S.E.M. Technetium-99m dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma: experience in imaging. J Nucl Med 30 (1989) 174-180
27. Jahde E., and Rajewsky M.F. Tumor-selective modification of cellular microenvironment in vivo: effect of glucose infusion on the pH in normal and malignant rat tissues. Cancer Res 42 (1982) 1505-1512
28. 188Re(V)-DMSA complex by cervical carcinoma cells in nude mice: pharmacokinetics and dosimetry. Appl Radiat Isot 54 (2001) 413-418
29. Horiuchi K., Saji H., and Yokoyama A. Tc(V)-DMS tumor localization mechanism: a pH-sensitive Tc(V)-DMS-enhanced target/nontarget ratio by glucose-mediated acidosis. Nucl Med Biol 25 (1998) 549-555
30. 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines. Eur J Nucl Med Mol Imaging 31 (2004) 77-84
31. Blower P.J., Singh J., and Clarke S.E. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid. J Nucl Med 32 (1991) 845-849
32. Kavanaugh M.P., and Kabat D. Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int 49 (1996) 959-963
33. +-dependent phosphate cotransporters: the NaPi protein families. J Exp Biol 201 (1998) 3135-3142
34. Horiuchi-Suzuki K., Konno A., Ueda M., Fukuda Y., Nishio S., Hashimoto K., et al. Skeletal affinity of Tc(V)-DMS is bone cell mediated and pH dependent. Eur J Nucl Med Mol Imaging 31 (2004) 388-398